课题基金 / 基金详情

Pathogenesis of Life Threatening Box Jellyfish Envenomation and Irukandji Syndrome

Pathogenesis of Life Threatening Box Jellyfish Envenomation and Irukandji Syndrome
危及生命的箱形水母中毒和伊鲁坎吉综合征的发病机制
批准号:
9331657
负责人:
ANGEL ANNE YANAGIHARA
金额:
$19.25万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2019-08-31
关键词:
Abdominal PainAcuteAddressAnimal ModelAnxietyArachidonic AcidsAreaAustraliaBiochemicalBiochemical MarkersBiogenic AminesBiologicalBiological AssayBiological ModelsBloodBlood CellsBlood PlateletsBlood PressureBlood gasBradycardiaCardiac OutputCaribbean regionCatecholaminesCell surfaceCellsCerebral hemisphere hemorrhageCessation of lifeChest PainClinicalComplementary DNAComplexCubozoaDevelopmentDiagnosticDoseElectrocardiogramEndothelial CellsErythrocytesEventFamilyFatal OutcomeFiltrationFloridaFunctional disorderGenetic TranscriptionGoalsGuamHawaiiHeadacheHeart RateHemolysisHourHumanHypertensionHypotensionImmuneIn VitroIncreased sweatingIndian OceanIndonesiaInflammatoryInjectableInjection of therapeutic agentJellyfishKidneyLifeLipaseLiquid substanceLungMarinesMeasuresMediterranean SeaMusNausea and VomitingOutputPainPathogenesisPathway interactionsPeptide HydrolasesPeripheral Blood Mononuclear CellPhysiologicalPlasmaPotassiumProteinsPublic HealthPuerto RicoPulmonary EdemaResearchResearch Project GrantsReverse Transcriptase Polymerase Chain ReactionRoleSamplingSharkSigns and SymptomsSiteSting InjuryStreptolysinsSuggestionSyndromeSystemTachycardiaTemperatureThailandTherapeuticTherapeutic InterventionTimeTissuesUnited States Virgin IslandsUrineVDAC1 geneVenomsWhole BloodWorkbasecardiovascular collapseclinically relevantclinically significantcytokinedesigneffective therapyevidence baseexperimental studyexposed human populationhyperkalemiaimprovedin vivoin vivo Modelinsightmonocyteperipheral bloodpressureresponseresponse biomarkerstandard of caretargeted treatmenttime use

项目摘要

项目成果

ANGEL ANNE YANAGIHARA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Box jellyfish envenomations account for myriad clinically significant sequelae, including debilitating sting-site pain and Irukandji syndrome, as well as in rare instances acute cardiovascular collapse and death, among residents and visitors to the U.S. coastal areas of Hawaii, Guam, Saipan, Florida, U.S. Virgin Islands and Puerto Rico. Cubozoan stings are also an increasing public health threat worldwide in tropical and subtropical areas of Australia, Indonesia, Thailand, Caribbean basin, Mediterranean Sea and Indian Ocean. Thus, there is an urgent need to better understand the pathogenesis of Irukandji syndrome, a potentially life-threatening sequelae with multi-systems symptoms and signs, suggestive of “cytokine storm” and “catecholamine surge”. Our long-term goal is to develop rapid diagnostics and effective treatments for the full spectrum of cubozoan envenomations. For the proposed research, our primary objective is to clarify the role of venom porins in the pathogenesis of Irukandji syndrome, by employing previously established in vitro and in vivo model systems. Our central hypothesis is that the cubozoan pore-forming proteins, or porins, induce a domino-type cascade of time-dependent pathophysiological effects on platelets, erythrocytes and peripheral blood mononuclear cells, including an initial dose-dependent release of biogenic amines and stored cytokines, which in turn causes a secondary induction of cytokine release from naïve leucocytes, as well as endothelial cells, that comprises Irukandji syndrome. A venom biochemist and an animal model expert will achieve the following specific aims. Aim 1. Compare the in vitro dose- and time-dependent effects of cubozoan whole venom and purified porin on human peripheral blood monocytes and platelets. Aim 2. Compare the in vivo dose-dependent effects of cubozoan whole venom and purified porin in piglets. Whole blood cell-based assays and a piglet animal model will be used to determine whether cubozoan porins cause specific systemic inflammatory effects and to track sequential physiological and biochemical responses in time-course experiments. Preliminary studies demonstrate that a central aspect of the pathogenesis of life- threatening jellyfish envenomation and Irukandji syndrome involves immune cell responses to cubozoan venom. Thus, this exploratory research project addresses a critical unmet need to better understand the pathophysiological role of cubozoan porin in order to develop rapid diagnostics and effective treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of Life Threatening Box Jellyfish Envenomation and Irukandji Syndrome
  • 批准号:
    9169580
  • 项目类别:
  • 资助金额:
    $23.1万
  • 财政年份:
    2016
  • 负责人:
    ANGEL ANNE YANAGIHARA
  • 依托单位:
Early Metazoan Nano-collagens for Promotion of Wound Healing
  • 批准号:
    8423396
  • 项目类别:
  • 资助金额:
    $28.57万
  • 财政年份:
    2011
  • 负责人:
    ANGEL ANNE YANAGIHARA
  • 依托单位:
Early Metazoan Nano-collagens for Promotion of Wound Healing
  • 批准号:
    8042806
  • 项目类别:
  • 资助金额:
    $31.73万
  • 财政年份:
    2011
  • 负责人:
    ANGEL ANNE YANAGIHARA
  • 依托单位:
Early Metazoan Nano-collagens for Promotion of Wound Healing
  • 批准号:
    8212104
  • 项目类别:
  • 资助金额:
    $30.08万
  • 财政年份:
    2011
  • 负责人:
    ANGEL ANNE YANAGIHARA
  • 依托单位:
海外基金